Estrogens and prostate cancer: etiology, mediators, prevention, and management.
about
Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer.Differential expression of estrogen receptor beta isoforms in prostate cancer through interplay between transcriptional and translational regulationHsa-miRNA-765 as a key mediator for inhibiting growth, migration and invasion in fulvestrant-treated prostate cancer.Estrogen modulation of the ethanol-evoked myocardial oxidative stress and dysfunction via DAPK3/Akt/ERK activation in male ratsEstrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden.Estrogen receptor β (ERβ1) transactivation is differentially modulated by the transcriptional coregulator Tip60 in a cis-acting element-dependent mannerGenetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.Editorial comment to involvement of estrogen receptors in prostatic diseases.Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer.Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.Occupational exposure to pesticides and prostate cancer: a systematic review and meta-analysis.Chronic exposure to arsenic, estrogen, and their combination causes increased growth and transformation in human prostate epithelial cells potentially by hypermethylation-mediated silencing of MLH1.Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.Urine of patients with early prostate cancer contains lower levels of light chain fragments of inter-alpha-trypsin inhibitor and saposin B but increased expression of an inter-alpha-trypsin inhibitor heavy chain 4 fragment.Molecular mechanisms involving prostate cancer racial disparity.Association between shift work and risk of prostate cancer: a systematic review and meta-analysis of observational studies.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.
P2860
Q34518031-4874F095-75CA-4E51-87A8-B6D2BB421571Q35056593-AD61386D-11FC-4B92-B41C-BF50BEF972C7Q35170430-61234085-D727-4FE3-9732-71088ABD9D1EQ35995425-D91FF4BF-5D76-4931-A93D-05A180FBCFABQ36434014-1A9283D2-AC4E-43FC-B404-951567AA8D72Q36661415-1B4FF33E-1D17-4C86-A55E-0BA7E00C7FE2Q37132032-3ABD26DB-F3A9-4A5C-BCC1-E4D71C6A59C4Q37139054-B227600E-C9CA-46BE-B0A7-BDA5407778BEQ37599474-84C6318E-4D9E-46DB-92C5-3D7030E91C1BQ38012493-7141251C-255D-45D9-9E2B-498FF3711B87Q38168954-981F559E-061B-4A65-A2A2-5A0CBC747EB3Q38587219-32BD67F5-6EA1-4AF2-99E5-649AE0E97AAAQ38661860-2A6FB262-2F71-4554-A99D-110CC4E65618Q39134469-C4C4148B-1C63-4948-80E8-1EB64448BC49Q40118262-DD95984F-0114-4DA4-A3C9-3DA56BD47C3BQ42508411-68E6EE0B-2688-43D4-8164-FC32E70749D4Q42573768-3B09A42C-1092-45D5-A789-2EF04A982652Q43614735-CB737486-7EE6-4354-B008-FF2AF9B08B7FQ45327318-16C3E6DF-6A1C-4242-858C-7B3D156E0A08Q47618504-D9A035C8-C6CD-446F-9CE2-DE61970A983DQ47805050-5C9689A8-256A-4758-810B-8DEFA2B61473Q48009111-DAD4C622-3758-48F3-8965-FCE4404A3439
P2860
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@ast
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@en
type
label
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@ast
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@en
prefLabel
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@ast
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
@en
P2093
P2860
P1476
Estrogens and prostate cancer: etiology, mediators, prevention, and management
@en
P2093
Hung-Ming Lam
Ming-Tsung Lee
Shuk-Mei Ho
P2860
P304
591-614, ix
P356
10.1016/J.ECL.2011.05.002
P577
2011-07-07T00:00:00Z